Logo image of AQNB

ALGONQUIN PWR & UTILITY - AQNCN 8.86372 07/01/2079 (AQNB) Stock Fundamental Analysis

NYSE:AQNB - New York Stock Exchange, Inc. - US0158578080

25.47  +0.11 (+0.43%)

Fundamental Rating

2

AQNB gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 25 industry peers in the Multi-Utilities industry. Both the profitability and financial health of AQNB have multiple concerns. AQNB does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year AQNB was profitable.
In the past year AQNB had a positive cash flow from operations.
Of the past 5 years AQNB 4 years were profitable.
In the past 5 years AQNB always reported a positive cash flow from operatings.
AQNB Yearly Net Income VS EBIT VS OCF VS FCFAQNB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M -1B

1.2 Ratios

AQNB has a worse Return On Assets (-6.24%) than 96.00% of its industry peers.
AQNB's Return On Equity of -22.90% is on the low side compared to the rest of the industry. AQNB is outperformed by 96.00% of its industry peers.
AQNB has a worse Return On Invested Capital (2.91%) than 88.00% of its industry peers.
AQNB had an Average Return On Invested Capital over the past 3 years of 2.30%. This is in line with the industry average of 3.68%.
The last Return On Invested Capital (2.91%) for AQNB is above the 3 year average (2.30%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -6.24%
ROE -22.9%
ROIC 2.91%
ROA(3y)0.13%
ROA(5y)2.2%
ROE(3y)0.18%
ROE(5y)5.78%
ROIC(3y)2.3%
ROIC(5y)2.45%
AQNB Yearly ROA, ROE, ROICAQNB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 10

1.3 Margins

AQNB's Profit Margin has declined in the last couple of years.
AQNB's Operating Margin of 19.49% is on the low side compared to the rest of the industry. AQNB is outperformed by 68.00% of its industry peers.
AQNB's Operating Margin has declined in the last couple of years.
AQNB has a Gross Margin of 74.55%. This is in the better half of the industry: AQNB outperforms 76.00% of its industry peers.
AQNB's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 19.49%
PM (TTM) N/A
GM 74.55%
OM growth 3Y-6.79%
OM growth 5Y-4.27%
PM growth 3Y-74.64%
PM growth 5Y-41.23%
GM growth 3Y-1.6%
GM growth 5Y0.32%
AQNB Yearly Profit, Operating, Gross MarginsAQNB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

More info and screens

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AQNB is destroying value.
The number of shares outstanding for AQNB has been increased compared to 1 year ago.
Compared to 5 years ago, AQNB has more shares outstanding
Compared to 1 year ago, AQNB has a worse debt to assets ratio.
AQNB Yearly Shares OutstandingAQNB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M
AQNB Yearly Total Debt VS Total AssetsAQNB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

2.2 Solvency

AQNB has an Altman-Z score of 0.97. This is a bad value and indicates that AQNB is not financially healthy and even has some risk of bankruptcy.
AQNB has a Altman-Z score of 0.97. This is in the better half of the industry: AQNB outperforms 80.00% of its industry peers.
AQNB has a Debt/Equity ratio of 1.49. This is a high value indicating a heavy dependency on external financing.
AQNB has a Debt to Equity ratio of 1.49. This is comparable to the rest of the industry: AQNB outperforms 52.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.49
Debt/FCF N/A
Altman-Z 0.97
ROIC/WACC0.44
WACC6.59%
AQNB Yearly LT Debt VS Equity VS FCFAQNB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B 4B 6B

2.3 Liquidity

AQNB has a Current Ratio of 0.92. This is a bad value and indicates that AQNB is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of AQNB (0.92) is better than 68.00% of its industry peers.
AQNB has a Quick Ratio of 0.92. This is a bad value and indicates that AQNB is not financially healthy enough and could expect problems in meeting its short term obligations.
AQNB has a Quick ratio of 0.77. This is comparable to the rest of the industry: AQNB outperforms 60.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.92
Quick Ratio 0.77
AQNB Yearly Current Assets VS Current LiabilitesAQNB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

More info and screens

3

3. Growth

3.1 Past

AQNB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.97%.
The Earnings Per Share has been decreasing by -4.95% on average over the past years.
The Revenue has grown by 13.32% in the past year. This is quite good.
The Revenue has been growing by 10.35% on average over the past years. This is quite good.
EPS 1Y (TTM)-18.97%
EPS 3Y-6.69%
EPS 5Y-4.95%
EPS Q2Q%-27.27%
Revenue 1Y (TTM)13.32%
Revenue growth 3Y17.17%
Revenue growth 5Y10.35%
Sales Q2Q%-8.24%

3.2 Future

AQNB is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -4.45% yearly.
Based on estimates for the next years, AQNB will show a decrease in Revenue. The Revenue will decrease by -0.28% on average per year.
EPS Next Y-24.64%
EPS Next 2Y-24.18%
EPS Next 3Y-12.49%
EPS Next 5Y-4.45%
Revenue Next Year-6.97%
Revenue Next 2Y-6.33%
Revenue Next 3Y-3.37%
Revenue Next 5Y-0.28%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AQNB Yearly Revenue VS EstimatesAQNB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B 2.5B
AQNB Yearly EPS VS EstimatesAQNB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 54.19, the valuation of AQNB can be described as expensive.
92.00% of the companies in the same industry are cheaper than AQNB, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of AQNB to the average of the S&P500 Index (28.29), we can say AQNB is valued expensively.
With a Price/Forward Earnings ratio of 85.20, AQNB can be considered very expensive at the moment.
AQNB's Price/Forward Earnings ratio is rather expensive when compared to the industry. AQNB is more expensive than 96.00% of the companies in the same industry.
AQNB's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 24.44.
Industry RankSector Rank
PE 54.19
Fwd PE 85.2
AQNB Price Earnings VS Forward Price EarningsAQNB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

AQNB's Enterprise Value to EBITDA ratio is rather expensive when compared to the industry. AQNB is more expensive than 96.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 24.19
AQNB Per share dataAQNB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

AQNB's earnings are expected to decrease with -12.49% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-24.18%
EPS Next 3Y-12.49%

More info and screens

5

5. Dividend

5.1 Amount

AQNB has a Yearly Dividend Yield of 5.90%, which is a nice return.
AQNB's Dividend Yield is rather good when compared to the industry average which is at 3.82. AQNB pays more dividend than 100.00% of the companies in the same industry.
AQNB's Dividend Yield is rather good when compared to the S&P500 average which is at 2.28.
Industry RankSector Rank
Dividend Yield 5.9%

5.2 History

The dividend of AQNB has a limited annual growth rate of 4.94%.
AQNB has been paying a dividend for over 5 years, so it has already some track record.
AQNB has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)4.94%
Div Incr Years1
Div Non Decr Years4
AQNB Yearly Dividends per shareAQNB Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 0.5 1 1.5

5.3 Sustainability

The earnings of AQNB are negative and hence is the payout ratio. AQNB will probably not be able to sustain this dividend level.
DP-28.84%
EPS Next 2Y-24.18%
EPS Next 3Y-12.49%
AQNB Yearly Income VS Free CF VS DividendAQNB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M -1B

More info and screens

ALGONQUIN PWR & UTILITY - AQNCN 8.86372 07/01/2079

NYSE:AQNB (1/22/2025, 11:18:53 AM)

25.47

+0.11 (+0.43%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)11-07 2024-11-07/bmo
Earnings (Next)N/A N/A
Inst Owners62.19%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap19.54B
Analysts67.69
Price Target23.64 (-7.18%)
Short Float %0%
Short Ratio0.23
Dividend
Industry RankSector Rank
Dividend Yield 5.9%
Yearly Dividend0.48
Dividend Growth(5Y)4.94%
DP-28.84%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.86%
Min EPS beat(2)-15.13%
Max EPS beat(2)13.41%
EPS beat(4)2
Avg EPS beat(4)-1.62%
Min EPS beat(4)-15.13%
Max EPS beat(4)13.41%
EPS beat(8)3
Avg EPS beat(8)-3.44%
EPS beat(12)4
Avg EPS beat(12)-5.16%
EPS beat(16)5
Avg EPS beat(16)-4.07%
Revenue beat(2)0
Avg Revenue beat(2)-2.63%
Min Revenue beat(2)-5.17%
Max Revenue beat(2)-0.08%
Revenue beat(4)1
Avg Revenue beat(4)-3.42%
Min Revenue beat(4)-9.57%
Max Revenue beat(4)1.13%
Revenue beat(8)4
Avg Revenue beat(8)-0.69%
Revenue beat(12)7
Avg Revenue beat(12)0.82%
Revenue beat(16)10
Avg Revenue beat(16)2.91%
PT rev (1m)7.45%
PT rev (3m)10.29%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-46.29%
EPS NY rev (1m)0%
EPS NY rev (3m)-15.04%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)1.24%
Revenue NY rev (3m)-3.57%
Valuation
Industry RankSector Rank
PE 54.19
Fwd PE 85.2
P/S 6.23
P/FCF N/A
P/OCF 30.81
P/B 4.03
P/tB 5.67
EV/EBITDA 24.19
EPS(TTM)0.47
EY1.85%
EPS(NY)0.3
Fwd EY1.17%
FCF(TTM)-0.39
FCFYN/A
OCF(TTM)0.83
OCFY3.25%
SpS4.09
BVpS6.31
TBVpS4.5
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.24%
ROE -22.9%
ROCE 3.69%
ROIC 2.91%
ROICexc 2.92%
ROICexgc 3.19%
OM 19.49%
PM (TTM) N/A
GM 74.55%
FCFM N/A
ROA(3y)0.13%
ROA(5y)2.2%
ROE(3y)0.18%
ROE(5y)5.78%
ROIC(3y)2.3%
ROIC(5y)2.45%
ROICexc(3y)2.31%
ROICexc(5y)2.46%
ROICexgc(3y)2.53%
ROICexgc(5y)2.73%
ROCE(3y)2.91%
ROCE(5y)3.1%
ROICexcg growth 3Y-2.44%
ROICexcg growth 5Y-7.49%
ROICexc growth 3Y-1.59%
ROICexc growth 5Y-6.9%
OM growth 3Y-6.79%
OM growth 5Y-4.27%
PM growth 3Y-74.64%
PM growth 5Y-41.23%
GM growth 3Y-1.6%
GM growth 5Y0.32%
F-Score6
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 1.49
Debt/FCF N/A
Debt/EBITDA 6.49
Cap/Depr 186.56%
Cap/Sales 29.67%
Interest Coverage 1.51
Cash Conversion 57.1%
Profit Quality N/A
Current Ratio 0.92
Quick Ratio 0.77
Altman-Z 0.97
F-Score6
WACC6.59%
ROIC/WACC0.44
Cap/Depr(3y)264.2%
Cap/Depr(5y)249.46%
Cap/Sales(3y)45.42%
Cap/Sales(5y)43.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.97%
EPS 3Y-6.69%
EPS 5Y-4.95%
EPS Q2Q%-27.27%
EPS Next Y-24.64%
EPS Next 2Y-24.18%
EPS Next 3Y-12.49%
EPS Next 5Y-4.45%
Revenue 1Y (TTM)13.32%
Revenue growth 3Y17.17%
Revenue growth 5Y10.35%
Sales Q2Q%-8.24%
Revenue Next Year-6.97%
Revenue Next 2Y-6.33%
Revenue Next 3Y-3.37%
Revenue Next 5Y-0.28%
EBIT growth 1Y21.37%
EBIT growth 3Y9.22%
EBIT growth 5Y5.64%
EBIT Next Year55.11%
EBIT Next 3Y12.57%
EBIT Next 5Y17.41%
FCF growth 1Y55.01%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y19.47%
OCF growth 3Y7.52%
OCF growth 5Y3.44%